Boston Scientific CEO says Congress should repeal device excise tax

07/5/2011 | Star Tribune (Minneapolis-St. Paul, Minn.)

Congress should work to rescind the 2.3% excise tax on medical devices in the health care law because it will stifle innovation and job growth, Boston Scientific President and CEO Ray Elliott writes in this Star Tribune opinion. Repealing the tax "would help protect the 2 million Americans whose jobs are supported by the medical technology sector and remove burdens on a uniquely American industry that collectively spends more than $10 billion annually on R&D, boasts a net trade surplus and has historically led the world in developing leading-edge medical technologies," Elliott writes.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health